Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities...
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects.
Dark chocolate enriched with extra virgin olive oil is associated with an improved cardiovascular risk profile, according to research presented today at ESC Congress.
Study suggests that middle-aged people who report that they are slow walkers could be at higher risk of heart disease compared to the general population.
Inflammatory hypothesis confirmed: Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events.
The risk of dying from rheumatic heart disease, a condition of damaged heart valves caused by bacterial infection that leads to rheumatic fever, has dropped around the world over the last 25 years...
Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death while few of those patients considered...
Most of us discard avocado seeds without a second thought, but a new study finds that the husk of these seeds may hold a treasure trove of health benefits.
Plant-based eating patterns continue to soar in popularity and a group of nutrition researchers outline the science behind this sustainable trend in a review paper, entitled "Cardiometabolic benefits...
Being both obese and healthy might be a myth, researchers say, pointing out that all overweight people are at an increased risk of coronary heart disease.
Exposure to high levels of air pollution increased stress hormone levels and negative metabolic changes in otherwise healthy, young adults in a recent study conducted in China.
A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease, according to a successful trial carried out in Finland.